News PageRareCyte RareCyte® selected for the Wellcome Leap In Utero program RareCyte Inc., ("RareCyte" or "The Company") a leading provider of Precision Biology products and services…Arboretum_JDNovember 16, 2022
Fifth EyeNews Page Fifth Eye Announces Andrew Malcolmson as new President & CEO Fifth Eye™, a leading provider of real-time AI-based clinical analytics today announced that its Board…Arboretum_JDNovember 2, 2022
Boomerang MedicalHome PageNews Page Bioelectronic Medicine Company Boomerang Medical Raises $15M in Series A Financing Returning investor Arboretum Ventures, joined by Hatteras Venture Partners, to fuel Boomerang Medical’s accelerated clinical…Arboretum_JDNovember 1, 2022